GB2232892B - Occlusive body for administering a physiologically active substance - Google Patents
Occlusive body for administering a physiologically active substanceInfo
- Publication number
- GB2232892B GB2232892B GB9014721A GB9014721A GB2232892B GB 2232892 B GB2232892 B GB 2232892B GB 9014721 A GB9014721 A GB 9014721A GB 9014721 A GB9014721 A GB 9014721A GB 2232892 B GB2232892 B GB 2232892B
- Authority
- GB
- United Kingdom
- Prior art keywords
- administering
- active substance
- physiologically active
- occlusive body
- occlusive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9014721A GB2232892B (en) | 1988-02-23 | 1989-02-23 | Occlusive body for administering a physiologically active substance |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888804164A GB8804164D0 (en) | 1988-02-23 | 1988-02-23 | Bandage for administering physiologically active compound |
PCT/GB1989/000185 WO1989007959A1 (en) | 1988-02-23 | 1989-02-23 | Occlusive body for administering a physiologically active substance |
GB9014721A GB2232892B (en) | 1988-02-23 | 1989-02-23 | Occlusive body for administering a physiologically active substance |
Publications (3)
Publication Number | Publication Date |
---|---|
GB9014721D0 GB9014721D0 (en) | 1990-10-03 |
GB2232892A GB2232892A (en) | 1991-01-02 |
GB2232892B true GB2232892B (en) | 1991-07-24 |
Family
ID=26293526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9014721A Expired - Lifetime GB2232892B (en) | 1988-02-23 | 1989-02-23 | Occlusive body for administering a physiologically active substance |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2232892B (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2314025B (en) * | 1996-06-13 | 2000-05-03 | Anthony Clive Umfrevill Fisher | Footwear deodoriser |
GB2336310B (en) | 1998-04-14 | 2003-09-10 | Stowic Resources Ltd | Method of manufacturing transdermal patches |
GB0102725D0 (en) * | 2001-02-02 | 2001-03-21 | Stowic Resources Ltd | Medical delivery system |
SI2068918T1 (en) | 2006-09-26 | 2012-09-28 | Infectious Disease Res Inst | Vaccine composition containing synthetic adjuvant |
US20090181078A1 (en) | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
EP2437753B1 (en) | 2009-06-05 | 2016-08-31 | Infectious Disease Research Institute | Synthetic glucopyranosyl lipid adjuvants and vaccine compositions containing them |
EA027236B1 (en) | 2011-04-08 | 2017-07-31 | Иммьюн Дизайн Корп. | Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses |
CN110339160A (en) | 2012-02-07 | 2019-10-18 | 传染性疾病研究院 | Improvement adjuvant formulation and its application method comprising TLR4 agonist |
MX350274B (en) | 2012-05-16 | 2017-08-31 | Immune Design Corp | Vaccines for hsv-2. |
BR112015025709A2 (en) | 2013-04-18 | 2017-07-18 | Immune Design Corp | gla monotherapy for cancer treatment |
US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
WO2015112485A1 (en) | 2014-01-21 | 2015-07-30 | Immune Design Corp. | Compositions for use in the treatment of allergic conditions |
KR102392974B1 (en) | 2016-05-16 | 2022-05-02 | 인펙셔스 디지즈 리서치 인스티튜트 (아이디알아이) | Formulations containing TLR agonists and methods of use |
WO2017200957A1 (en) | 2016-05-16 | 2017-11-23 | Infectious Disease Research Institute | Pegylated liposomes and methods of use |
MX2021010105A (en) | 2016-06-01 | 2022-06-16 | Infectious Disease Res Inst | Nanoalum particles containing a sizing agent. |
AU2018283973A1 (en) | 2017-06-11 | 2020-01-16 | Molecular Express, Inc. | Methods and compositions for substance use disorder vaccine formulations and uses thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3598122A (en) * | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US4067961A (en) * | 1975-03-19 | 1978-01-10 | The Procter & Gamble Company | Controlled release article |
EP0186019A2 (en) * | 1984-12-22 | 1986-07-02 | Schwarz Pharma Ag | Medicated dressing |
EP0197504A2 (en) * | 1985-04-05 | 1986-10-15 | Merck & Co. Inc. | pH-mediated drug delivery system |
GB2174605A (en) * | 1985-05-03 | 1986-11-12 | Alza Corp | Transdermal drug delivery |
EP0208395A1 (en) * | 1985-05-16 | 1987-01-14 | Euroceltique S.A. | Transdermal delivery system |
-
1989
- 1989-02-23 GB GB9014721A patent/GB2232892B/en not_active Expired - Lifetime
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3598122A (en) * | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3598122B1 (en) * | 1969-04-01 | 1982-11-23 | ||
US4067961A (en) * | 1975-03-19 | 1978-01-10 | The Procter & Gamble Company | Controlled release article |
EP0186019A2 (en) * | 1984-12-22 | 1986-07-02 | Schwarz Pharma Ag | Medicated dressing |
EP0197504A2 (en) * | 1985-04-05 | 1986-10-15 | Merck & Co. Inc. | pH-mediated drug delivery system |
GB2174605A (en) * | 1985-05-03 | 1986-11-12 | Alza Corp | Transdermal drug delivery |
EP0208395A1 (en) * | 1985-05-16 | 1987-01-14 | Euroceltique S.A. | Transdermal delivery system |
Non-Patent Citations (1)
Title |
---|
International Journal of Pharmaceutics, vol. 48, 1988, pages247-254 * |
Also Published As
Publication number | Publication date |
---|---|
GB2232892A (en) | 1991-01-02 |
GB9014721D0 (en) | 1990-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA891403B (en) | Occlusive body for administering a physiologically active substance | |
GR1002252B (en) | A novel therapeutic active compound and preparation method therefore. | |
GB8828477D0 (en) | Medical aerosol formulations | |
AU2550288A (en) | A medical device for introduction into a body cavity | |
GB2232892B (en) | Occlusive body for administering a physiologically active substance | |
AU3926589A (en) | Pharmaceutical compounds exhibiting somatostatin-like activity | |
SG86966A1 (en) | Medicament for augmenting fetal hemoglobin | |
ZA898201B (en) | Gestodene-containing agent for transdermal administration | |
EP0294053A3 (en) | Physiologically active agent for agricultural use | |
EP0450100A4 (en) | Physiologically active peptide | |
AU8303687A (en) | Composition for administration through a body cavity | |
ZA899948B (en) | Pharmaceutical preparation | |
EP0455818A4 (en) | Physiologically active substance be-16627 | |
HK37795A (en) | Pharmaceutically active dithioketene derivatives | |
GB8802391D0 (en) | Medicinal formulations | |
AU8640491A (en) | Device for administering a physiologically active substance to the gastro-intestinal tract | |
GB8805811D0 (en) | Pharmaceutically active compounds | |
IE882467L (en) | Pharmaceutical preparation for external use | |
GB8901158D0 (en) | Administering drugs | |
GB8914384D0 (en) | A capsule for a medicament | |
BG48198A1 (en) | Active sonorifying body | |
SG171194G (en) | Pharmaceutically active dithioketene derivatives | |
GB8821120D0 (en) | Therapeutic substance | |
GB8814742D0 (en) | Medicament inhalation device | |
GB8809045D0 (en) | Therapeutic agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) | ||
732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) | ||
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20080223 |